Clinical and Molecular Hepatology

Articles in E-pub version are posted online ahead of regular printed publication.

Replys to Correspondence Complement Proteins and Liver Diseases: A Response to the Correspondence: Mohammad Saeid Rezaee-Zavareh, Naomy Kim, Ju Dong Yang; DOI: 10.3350/cmh.2024.0320 [Epub ahead of print]

Letters to the Editor Functional cure of CHB encounters resmetirom: Nai-Bin Yang, Wai-Kay Seto, Ming-Hua Zheng; DOI: 10.3350/cmh.2024.0301 [Epub ahead of print]

Reviews Unmet needs in the post-DAA era: the risk and molecular mechanisms of hepatocellular carcinoma after HCV eradication: Chung-Feng Huang, Manar Hijaze Awad, Meital Gal-Tanamy, Ming-Lung Yu; DOI: 10.3350/cmh.2024.0155 [Epub ahead of print]

Original Articles Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy: Pei-Chien Tsai, Chung-Feng Huang, Ming-Lun Yeh, Meng-Hsuan Hsieh, Hsing-Tao Kuo, Chao-Hung Hung, Kuo-Chih Tseng, Hsueh-Chou Lai, Cheng-Yuan Peng, Jing-Houng Wang, Jyh-Jou Chen, Pei-Lun Lee, Rong-Nan Chien, Chi-Chieh Yang, Gin-Ho Lo, Jia-Horng Kao, Chun-Jen Liu, Chen-Hua Liu, Sheng-Lei Yan, Chun-Yen Lin, Wei-Wen Su, Cheng-Hsin Chu, Chih-Jen Chen, Shui-Yi Tung, Chi‐Ming Tai, Chih-Wen Lin, Ching-Chu Lo, Pin-Nan Cheng, Yen-Cheng Chiu, Chia-Chi Wang, Jin-Shiung Cheng, Wei-Lun Tsai, Han-Chieh Lin, Yi-Hsiang Huang, Chi-Yi Chen, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Wan-Long, Ming-Jong Bair, Ming-Lung Yu; DOI: 10.3350/cmh.2024.0038 [Epub ahead of print]

Global prevalence of MAFLD-related hepatocellular carcinoma: A systematic review and meta-analysis: Harry Crane, Guy D. Eslick, Cameron Gofton, Anjiya Shaikh, George Cholankeril, Mark Cheah, Jian-Hong Zhong, Gianluca Svegliati-Baroni, Alessandro Vitale, Beom Kyung Kim, Sang Hoon Ahn, Mi Na Kim, Simone Strasser, Jacob George; DOI: 10.3350/cmh.2024.0109 [Epub ahead of print]

Ursolic acid targets secreted phosphoprotein 1 to regulate Th17 cells against non-alcoholic fatty liver disease: Yiyuan Zheng, Lina Zhao, Zhekun Xiong, Chaoyuan Huang, Qiuhong Yong, Dan Fang, Yugang Fu, Simin Gu, Chong Chen, Jiacheng Li, Yingying Zhu, Jing Liu, Fengbin Liu, Yong Li; DOI: 10.3350/cmh.2024.0047 [Epub ahead of print]

Replys to correspondence Reply to Correspondence: Atsumasa Komori; DOI: 10.3350/cmh.2024.0242 [Epub ahead of print]

Reply to “Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide fumarate in HBV patients”: Pin-Nan Cheng, Ming-Lung Yu; DOI: 10.3350/cmh.2024.0228 [Epub ahead of print]

Original Articles Ischemia-free liver transplantation improves the prognosis of recipients using Functioned Marginal Liver grafts: Shuai Wang, Xiaohong Lin, Yunhua Tang, Yichen Liang, Min Zhang, Zhonghao Xie, Yiwen Guo, Yuqi Dong, Qiang Zhao, Zhiyong Guo, Dongping Wang, Xiaoshun He, Weiqiang Ju, Maogen Chen; DOI: 10.3350/cmh.2024.0139 [Epub ahead of print]

Conventional and machine-learning based risk score for patients with early-stage hepatocellular carcinoma: Chun-Ting Ho, Elise Chia-Hui Tan, Pei-Chang Lee, Chi-Jen Chu, Yi-Hsiang Huang, Teh-Ia Huo, Yu-Hui Su, Ming-Chih Hou, Jaw-Ching Wu, Chien-Wei Su; DOI: 10.3350/cmh.2024.0103 [Epub ahead of print]

Dynamic Assessment of Modified Quick Sequential Organ Failure Assessment in Acutely Deteriorated Patients with Chronic Liver Disease: Do Seon Song, Hee Yeon Kim, Young Kul Jung, Tae Hyung Kim, Hyung Joon Yim, Eileen L Yoon, Ki Tae Suk, Jeong-ju Yoo, Sang Gyune Kim, Moon Young Kim, Young Chang, Soung Won Jeong, Jae Young Jang, Sung-Eun Kim, Jung-Hee Kim, Jung Gil Park, Won Kim, Jin Mo Yang, Dong Joon Kim, Ashok Kumar Choudhury, Vinod Arora, Shiv Kumar Sarin; DOI: 10.3350/cmh.2023.0563 [Epub ahead of print]

Phase 1 Trial of the Safety, Pharmacokinetics, and Antiviral Activity of EDP-514 in Untreated Viremic Chronic Hepatitis B Patients: Man-Fung Yuen, Wan-Long Chuang, Cheng-Yuan Peng, Wen-Juei Jeng, Wei-Wen Su, Ting-Tsung Chang, Chi-Yi Chen, Yao-Chun Hsu, Guy De La Rosa, Alaa Ahmad, Ed Luo, Annie L. Conery; DOI: 10.3350/cmh.2023.0535 [Epub ahead of print]

Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma: Jiwon Hong, Jung Woo Eun, Geum Ok Baek, Jae Youn Cheong, Seryoung Park, Soon Sun Kim, Hyo Jung Cho, Su Bin Lim; DOI: 10.3350/cmh.2024.0042 [Epub ahead of print]

Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after Atezolizumab/Bevacizumab Failure: A real-world study: Young Eun Chon, Dong Yun Kim, Mina Kim, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Sang Hoon Ahn, Yeonjung Ha, Joo Ho Lee, Kwan Sik Lee, Beodeul Kang, Jung Sun Kim, Hong Jae Chon, Do Young Kim; DOI: 10.3350/cmh.2023.0553 [Epub ahead of print]

Letters to the Editor Changing from NAFLD to MASLD: Prevalence and progression of ASCVD risk are similar between NAFLD and MASLD in Asia: Hiroyuki Suzuki, Tsubasa Tsutsumi, Machiko Kawaguchi, Keisuke Amano, Takumi Kawaguchi; DOI: 10.3350/cmh.2024.0157 [Epub ahead of print]

Snapshots EXAMINING THE THERAPEUTIC LANDSCAPE OF BETA-BLOCKERS IN PORTAL HYPERTENSION: Anna Brujats, Càndid Villanueva; DOI: 10.3350/cmh.2024.0144 [Epub ahead of print]

Reviews Liver sinusoidal endothelial cell: An important yet often overlooked player in the liver fibrosis: Jiaorong Qu, Le Wang, Yufei Li, Xiaojiaoyang Li; DOI: 10.3350/cmh.2024.0022 [Epub ahead of print]